Recently a G-protein-coupled receptor, MAS Related GPR Family Member X2 (MRGPRX2), was identified as a specific receptor on human mast cells responsible for IgE independent adverse drug reactions (ADR). Although a murine homologue, Mrgprb2, has been identified for this receptor, its affinity for many ADR-causing drugs is poor making it difficult to undertake in vivo studies to examine mechanisms of ADR and to develop therapeutic strategies. Here, we have created humanized mice capable of generating MRGPRX2-expressing human MCs allowing for the study of MRGPRX2 MCs-mediated ADR in vitro as well as in vivo. Humanized mice were generated by hydrodynamic-injection of plasmids expressing human GM-CSF and IL-3 into NOD-scid IL2R-γ−/− strain of mice that had been transplanted with human hematopoietic stem cells. These GM/IL-3 humice expressed high numbers of tissue human MCs but the MRGPRX2 receptor expressed in MCs were limited to few body sites including the skin. Importantly, large numbers of MRGPRX2-expressing human MCs could be cultured from the bone marrow of GM/IL-3 humice revealing these mice to be an important source of human MCs for in vitro studies of MRGPRX2-related MCs activities. When GM/IL-3 humice were exposed to known ADR causing contrast agents (meglumine and gadobutrol), the humice were found to experience anaphylaxis analogous to the clinical situation. Thus, GM/IL-3 humice represent a valuable model for investigating in vivo interactions of ADR-causing drugs and human MCs and their sequelae, and these mice are also a source of human MRGPRX2-expressing MCs for in vitro studies.
Bibliographical noteFunding Information:
This study was supported by National Medical Research Council Singapore, NMRC/TCR/014‐NUHS/2015, NMRC/CSA‐SI/0013/2017 and NMRC/OFLCG/003/2018 to Q.C. and a block grant award from Duke‐NUS to SNA. National Research Foundation Fellowship Singapore NRF‐NRFF2017‐03 to Q.C. and the Chinese National Nature Science Foundation 81570101 to Y.F.
This study was supported by National Medical Research Council Singapore, NMRC/TCR/014-NUHS/2015, NMRC/CSA-SI/0013/2017 and NMRC/OFLCG/003/2018 to Q.C. and a block grant award from Duke-NUS to SNA. National Research Foundation Fellowship Singapore NRF-NRFF2017-03 to Q.C. and the Chinese National Nature Science Foundation 81570101 to Y.F.
© 2020 The Authors. Journal of Leukocyte Biology published by Wiley Periodicals, Inc. on behalf of Society for Leukocyte Biology
- MRGPRX2 receptor
- contrast agents
- mast cells
- non-immune adverse drug reactions
ASJC Scopus subject areas
- Immunology and Allergy
- Cell Biology